Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;31(7):4908-4917.
doi: 10.1007/s00330-020-07545-7. Epub 2021 Jan 4.

MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences

Affiliations

MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences

Vlad Bura et al. Eur Radiol. 2021 Jul.

Abstract

Objectives: To assess the multiparametric MRI (mpMRI) appearances of normal peripheral zone (PZ) across age groups in a biopsy-naïve population, where prostate cancer (PCa) was subsequently excluded, and propose a scoring system for background PZ changes.

Methods: This retrospective study included 175 consecutive biopsy-naïve patients (40-74 years) referred with a suspicion of PCa, but with subsequent negative investigations. Patients were grouped by age into categories ≤ 54, 55-59, 60-64, and ≥ 65 years. MpMRI sequences (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI]/apparent diffusion coefficient [ADC], and dynamic contrast-enhanced imaging [DCE]) were independently evaluated by two uro-radiologists on a proposed 4-point grading scale for background change on each sequence, wherein score 1 mirrored PIRADS-1 change and score 4 represented diffuse background change. Peripheral zone T2WI signal intensity and ADC values were also analyzed for trends relating to age.

Results: There was a negative correlation between age and assigned background PZ scores for each mpMRI sequence: T2WI: r = - 0.52, DWI: r = - 0.49, DCE: r = - 0.45, p < 0.001. Patients aged ≤ 54 years had mean scores of 3.0 (T2WI), 2.7 (DWI), and 3.1 (DCE), whilst patients ≥ 65 years had significantly lower mean scores of 1.7, 1.4, and 1.9, respectively. There was moderate inter-reader agreement for all scores (range κ = 0.43-0.58). Statistically significant positive correlations were found for age versus normalized T2WI signal intensity (r = 0.2, p = 0.009) and age versus ADC values (r = 0.33, p = 0.001).

Conclusion: The normal PZ in younger patients (≤ 54 years) demonstrates significantly lower T2WI signal intensity, lower ADC values, and diffuse enhancement on DCE, which may hinder diagnostic interpretation in these patients. The proposed standardized PZ background scoring system may help convey the potential for diagnostic uncertainty to clinicians.

Key points: • Significant, positive correlations were found between increasing age and higher normalized T2-weighted signal intensity and mean ADC values of the prostatic peripheral zone. • Younger men exhibit lower T2-weighted imaging signal intensity, lower ADC values, and diffuse enhancement on dynamic contrast-enhanced imaging, which may hinder MRI interpretation. • A scoring system is proposed which aims towards a standardized assessment of the normal background PZ. This may help convey the potential for diagnostic uncertainty to clinicians.

Keywords: Aging; Anatomy; Multiparametric MRI; Normal anatomy; Prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Figures

Fig. 1
Fig. 1
Image examples of T2-weighted imaging scores 1 to 4. Detailed descriptors can be found in Table 1
Fig. 2
Fig. 2
A 44-year-old man with a family history of prostate cancer, PSA 0.5 ng/mL and subsequent negative transrectal-ultrasound-guided biopsy. T2-weighted (a), early-phase dynamic contrast-enhanced (b), b-2000 diffusion-weighted (c), and apparent diffusion coefficient map (d) images show features of score 4 for each of the individual sequences
Fig. 3
Fig. 3
Relationships between (a) age and whole gland (WG) volume and (b) age and transition zone (TZ) volume, on MRI (n = 174, 1 outlier excluded). The graphs show that both WG and TZ volumes increase with increasing age
Fig. 4
Fig. 4
T2-weighted imaging (T2WI) score distribution among the four age groups (≤ 54, 55–59, 60–64, and ≥ 65 years); scores reduce with increasing age
Fig. 5
Fig. 5
Relationship between age and T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores. Scores reduce as age increases
Fig. 6
Fig. 6
Relationship between age and peripheral zone (PZ) normalized T2-weighted imaging (T2WI) signal intensity. The graph shows T2WI signal intensity increases with increasing age

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I (2018) Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 394–424. 10.3322/caac.21492 - PubMed
    1. Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004;172:1297–1301. doi: 10.1097/01.ju.0000139993.51181.5d. - DOI - PubMed
    1. US Preventive Services Task Force (2018) Final Recommendation Statement: Prostate Cancer: Screening. US Preventive Services Task Force, Rockville, MD, USA. Available via https://www.uspreventiveservicestaskforce.org/Page/Document/Recommendati.... Accessed 17 Jun 2020
    1. Fulgham PF, Rukstalis DB, Turkbey IB, et al. AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol. 2017;198:832–838. doi: 10.1016/j.juro.2017.04.101. - DOI - PMC - PubMed
    1. Mottet N, van den Bergh RCN, Briers E, et al (2020) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 10.1016/j.eururo.2020.09.042 - PubMed

LinkOut - more resources